S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 203 SEK -1.93% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Stille AB?
Write Note

Stille AB
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stille AB
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Stille AB
STO:STIL
Total Liabilities & Equity
kr1B
CAGR 3-Years
49%
CAGR 5-Years
46%
CAGR 10-Years
34%
Elekta AB (publ)
STO:EKTA B
Total Liabilities & Equity
kr31.4B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Total Liabilities & Equity
kr4.8B
CAGR 3-Years
8%
CAGR 5-Years
60%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Total Liabilities & Equity
kr983.8m
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
18%
Getinge AB
STO:GETI B
Total Liabilities & Equity
kr53.6B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Total Liabilities & Equity
kr15.4B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
No Stocks Found

Stille AB
Glance View

Market Cap
1.8B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
286.89 SEK
Undervaluation 29%
Intrinsic Value
Price
S

See Also

What is Stille AB's Total Liabilities & Equity?
Total Liabilities & Equity
1B SEK

Based on the financial report for Sep 30, 2024, Stille AB's Total Liabilities & Equity amounts to 1B SEK.

What is Stille AB's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
34%

Over the last year, the Total Liabilities & Equity growth was 177%. The average annual Total Liabilities & Equity growth rates for Stille AB have been 49% over the past three years , 46% over the past five years , and 34% over the past ten years .

Back to Top